Pune: Serum Institute of India (SII), on Sunday, issued a clarification that the current claims over commercialising COVISHIELD’s availability in 73 days, in the media is completely false and conjectural.
The official handle of the institute took to Twitter to issue the clarification.
“Presently, the government has granted us permission to only manufacture the vaccine and stockpile it for future use. COVISHIELD will be commercialised once the trials are proven successful and all the requisite regulatory approvals are in place,” said the notice by SII.
“The phase-3 trials for the Oxford-AstraZeneca vaccine, are still underway. And only once the vaccine is proven immunogenic and efficacious, SII will confirm its availability, officially.”
After an embarrassing whitewash, straight into a test by fire. Team India won't find it…
Celebrity couple Abhishek Bachchan and Aishwarya apparently have some problems in their marriage. As news…
Bhubaneswar: A day after indictment of Gautam Adani in the US in a fraud scheme,…
New York: US President-elect Donald Trump on Thursday nominated Pam Bondi, the former attorney general…
Koraput: Police on Friday claimed to have busted a ganja smuggling racket being carried out…
New York: The recent indictment of top executives of Adani Group, including its chairperson Gautam…
Bhubaneswar: The result of the Odisha Teacher's Eligibility Test (OTET)-2024 was announced on Friday. The…
Bhubaneswar: An attempt for an amicable settlement of the dispute, involving Ollywood director Bobby Islam…